Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
Κύριοι συγγραφείς: | Campbell, A, Ait-Tahar, K, Patel, S, Barnardo, M, Liggins, A, Caibes, M, Banham, A, Collins, G, Hatton, C, Pulford, K |
---|---|
Μορφή: | Conference item |
Έκδοση: |
2010
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
PASD1 is a potential multiple myeloma-associated antigen.
ανά: Sahota, S, κ.ά.
Έκδοση: (2006) -
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
ανά: Cooper, C, κ.ά.
Έκδοση: (2006) -
Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
ανά: Ait-Tahar, K, κ.ά.
Έκδοση: (2009) -
Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
ανά: Ait-Tahar, K, κ.ά.
Έκδοση: (2009) -
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
ανά: Joseph-Pietras, D, κ.ά.
Έκδοση: (2010)